Skip to Main Content

Paper Details

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy.
Front Immunol
6
2023
Author NameAffiliation
Natasha B HalasaVanderbilt University Medical Center
  • 1 - 1

Datasets

Release 1.2